When does the bictegravir patent expire?
I don’t have enough specific, jurisdiction-level patent data in the provided information to state an exact bictegravir patent expiry date. Patent expiry depends on factors like the filing date of the specific patent family, where it was filed (country/region), and whether any extensions (for example, patent term adjustments/extensions or supplementary protection certificates) apply.
Which bictegravir product patents matter (Biktarvy vs. generic bictegravir)?
Bictegravir is marketed as part of combination therapy (most notably Biktarvy). For launch timing of competitors, what matters is usually the expiry of patents tied to:
- the active ingredient (bictegravir) itself, and
- the specific formulation and/or combination regimen (because combination and formulation patents can extend exclusivity even after an API patent term ends).
Can generics or biosimilars enter before bictegravir’s patents expire?
Often, generic manufacturers can file applications before patent expiry (for regulatory approval pathways), but they may be blocked from marketing until the relevant patents and any regulatory exclusivities have ended. Whether early approval is possible and whether it results in a market launch depends on the country’s “patent linkage” and approval rules and on which patents are asserted.
Why expiry dates differ by country (and why your date may be wrong if it’s “global”)
Even if the underlying invention filing is the same, expiry can differ because:
- patent grant and term rules vary by jurisdiction,
- some countries apply different maximum term calculations, and
- extensions or secondary patents can keep the product protected longer.
What you can check to get the exact expiry date you need
To pin down the exact “bictegravir patent expiry” for your location, you typically need:
- the target country/region (US, EU/UK, Canada, etc.),
- the exact patent family (or at least the product/regimen and dosage form), and
- the status of related patents (granted, pending, expired, or under litigation).
If you tell me your country, I can narrow it down
If you share the jurisdiction you care about (for example, US or EU/UK) and whether you mean bictegravir as an ingredient or the Biktarvy combination, I can help map the correct patent families to an expiry timeline using the relevant legal framework.
Sources
No sources were provided with the question, so I’m not able to cite specific patent expiry dates.